Trastuzumab and chemotherapy may be appropriate for small, node-negative, HER2-positive breast cancer.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1634/theoncologist.2012-0318

Topics

  • Presentations referencing similar topics